3rd Quarter - Report
THE DUBERSTEIN GROUP INC. for PFIZER INC.
Client
Income
$60,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
Biosimilar utilization
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID J SCHIAPPA | — |
Health Issues HCR
General Outreach / Introductions Drug Pricing TRIPS waiver H.R.3 (Pallone) - Elijah E. Cummings Lower Drug Costs Now Act H.R.1978 (Kuster) - Protecting Seniors Through Immunization Act of 2021 Outreach regarding pharmaceutical supply chain issues MADE Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| BRIAN GRIFFIN | — |
| BENJAMIN R HOWARD | — |
| KATHERINE WINKLER KEATING | — |
| ELIZABETH KELLEY New | Special Asst to POTUS and COS of Natl Econ Council; Asst US Trade Rep for Private Sector Engagement; COS, Sen. John Walsh; Deputy COS, Sen. Max Baucus; Exec Asst and Deputy Press Sec, Rep. Earl Blumenauer |
| DAVID J SCHIAPPA | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.